Our study provides insight into the reduced expression of RXFP1 in patients with IPF and may support efforts to restore the effectiveness of relaxin-based therapeutics in fILD through the upregulation of RXFP1 transcription. This evidence concerns the gene RXFP1 and idiopathic pulmonary fibrosis.